The Alpha variant of SARS-CoV-2-;the first "variant of concern"-;evolved mutations that allowed it to more efficiently suppress the immune system's early response to infection, according to a new study led by scientists at the University of California, San Francisco's Quantitative Biosciences Institute and University College London.